Connection
Brad Constant to Ustekinumab
This is a "connection" page, showing publications Brad Constant has written about Ustekinumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.237 |
|
|
|
-
Mitchel EB, Dolinger MT, Constant B, Wang Z, Guisado D, Gao M, Fusillo S, Baldassano RN, Kelsen J, Dubinsky M, Huang J, Albenberg L. Ustekinumab is safe and effective in pediatric patients with Crohn's disease. J Pediatr Gastroenterol Nutr. 2025 Apr; 80(4):653-663.
Score: 0.237